A sub-set of cancers that are exposed to high drug concentrations due to a special location (e.g., urine-exposed superficial bladder cancer)41 or if they originate from tissues with high OCT expression (e.g., liver, kidney), assuming that high expression is maintained during oncogenesis, may exist. Here, PLXNA2 is linked to cancer.